182 related articles for article (PubMed ID: 18608912)
1. Antibody responses to Cryptococcus neoformans in Indian patients with cryptococcosis.
Saha DC; Xess I; Zeng WY; Goldman DL
Med Mycol; 2008 Aug; 46(5):457-63. PubMed ID: 18608912
[TBL] [Abstract][Full Text] [Related]
2. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection.
Abadi J; Pirofski La
J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394
[TBL] [Abstract][Full Text] [Related]
3. Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.
Lamura L; Matthews RC; Barchiesi F; Donahoe M; Burnie JP; Scalise G
J Infect; 2000 Jan; 40(1):64-8. PubMed ID: 10762114
[TBL] [Abstract][Full Text] [Related]
4. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.
Zhang H; Zhong Z; Pirofski LA
Infect Immun; 1997 Apr; 65(4):1158-64. PubMed ID: 9119446
[TBL] [Abstract][Full Text] [Related]
5. Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation.
Jalali Z; Ng L; Singh N; Pirofski LA
Clin Vaccine Immunol; 2006 Jul; 13(7):740-6. PubMed ID: 16829610
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.
Subramaniam K; French N; Pirofski LA
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1168-76. PubMed ID: 16210479
[TBL] [Abstract][Full Text] [Related]
7. Serologic evidence for Cryptococcus neoformans infection in early childhood.
Goldman DL; Khine H; Abadi J; Lindenberg DJ; Pirofski La ; Niang R; Casadevall A
Pediatrics; 2001 May; 107(5):E66. PubMed ID: 11331716
[TBL] [Abstract][Full Text] [Related]
8. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
Pirofski LA
Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals.
Deshaw M; Pirofski LA
Clin Exp Immunol; 1995 Mar; 99(3):425-32. PubMed ID: 7882565
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection.
Feldmesser M; Casadevall A
Front Biosci; 1998 Feb; 3():d136-51. PubMed ID: 9445465
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.
Maitta RW; Datta K; Lees A; Belouski SS; Pirofski LA
Infect Immun; 2004 Jan; 72(1):196-208. PubMed ID: 14688097
[TBL] [Abstract][Full Text] [Related]
12. Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.
Casadevall A; Mukherjee J; Devi SJ; Schneerson R; Robbins JB; Scharff MD
J Infect Dis; 1992 Jun; 165(6):1086-93. PubMed ID: 1583327
[TBL] [Abstract][Full Text] [Related]
13. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
[TBL] [Abstract][Full Text] [Related]
14. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection.
Fleuridor R; Lees A; Pirofski L
J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to Cryptococcus neoformans proteins in rodents and humans.
Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A
Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877
[TBL] [Abstract][Full Text] [Related]
16. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
Parra C; González JM; Castañeda E; Fiorentino S
Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
[TBL] [Abstract][Full Text] [Related]
17. A novel ELISA for determination of polysaccharide specific immunoglobulins.
Spoljar BH; Tomasic J
Vaccine; 2000 Nov; 19(7-8):924-30. PubMed ID: 11115717
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.
Kakeya H; Udono H; Maesaki S; Sasaki E; Kawamura S; Hossain MA; Yamamoto Y; Sawai T; Fukuda M; Mitsutake K; Miyazaki Y; Tomono K; Tashiro T; Nakayama E; Kohno S
Clin Exp Immunol; 1999 Mar; 115(3):485-90. PubMed ID: 10193422
[TBL] [Abstract][Full Text] [Related]
19. Detection of IgM and IgG antibodies to Cryptococcus neoformans proteins in blood donors and HIV patients with active cryptococcosis.
Chai HC; Tay ST
Mycoses; 2009 Mar; 52(2):166-70. PubMed ID: 18643920
[TBL] [Abstract][Full Text] [Related]
20. Methods of Cryptococcal Polysaccharide Analysis Using ELISA.
Wear MP; McConnell SA; Greengo SD; Lopes LL; Casadevall A
Methods Mol Biol; 2024; 2775():239-255. PubMed ID: 38758322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
